Literature DB >> 8103404

Discordant phenotype of two overlapping deletions involving the PAX3 gene in chromosome 2q35.

N G Pasteris1, B J Trask, S Sheldon, J L Gorski.   

Abstract

Waardenburg syndrome (WS), the most common form of inherited congenital deafness, is a pleiotropic, autosomal dominant condition with variable penetrance and expressivity. WS is clinically and genetically heterogeneous. The basis for the phenotypic variability observed among and between WS families is unknown. However, mutations within the paired-box gene, PAX3, have been associated with a subset of WS patients. In this report we use cytogenetic and molecular genetic techniques to study a patient with WS type 3, a form of WS consisting of typical WS type 1 features plus mental retardation, microcephaly, and severe skeletal anomalies. Our results show that the WS3 patient has a de novo paternally derived deletion, del (2)(q35q36), that spans the genetic loci PAX3 and COL4A3. A molecular analysis of a chromosome 2 deletional mapping panel maps the PAX3 locus to 2q35 and suggests the locus order: centromere-(INHA, DES)-PAX3-COL4A3-(ALPI, CHRND)-telomere. Our analyses also show that a patient with a cleft palate and lip pits, but lacking diagnostic WS features, has a deletion, del (2)(q33q35), involving the PAX3 locus. This result suggests that not all PAX3 mutations are associated with a WS phenotype and that additional regional loci may modify or regulate the PAX3 locus and/or the development of a WS phenotype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8103404     DOI: 10.1093/hmg/2.7.953

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  11 in total

1.  Assignment of the IA-2 gene encoding an autoantigen in IDDM to chromosome 2q35.

Authors:  M S Lan; W S Modi; H Xie; A L Notkins
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

2.  A cryptic deletion of 2q35 including part of the PAX3 gene detected by breakpoint mapping in a child with autism and a de novo 2;8 translocation.

Authors:  I Borg; M Squire; C Menzel; K Stout; D Morgan; L Willatt; P C M O'Brien; M A Ferguson-Smith; H H Ropers; N Tommerup; V M Kalscheuer; D R Sargan
Journal:  J Med Genet       Date:  2002-06       Impact factor: 6.318

3.  Locus heterogeneity for Waardenburg syndrome is predictive of clinical subtypes.

Authors:  L A Farrer; K S Arnos; J H Asher; C T Baldwin; S R Diehl; T B Friedman; J Greenberg; K M Grundfast; C Hoth; A K Lalwani
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

4.  Chromosome 13q deletion with Waardenburg syndrome: further evidence for a gene involved in neural crest function on 13q.

Authors:  G Van Camp; M N Van Thienen; I Handig; B Van Roy; V S Rao; A Milunsky; A P Read; C T Baldwin; L A Farrer; M Bonduelle
Journal:  J Med Genet       Date:  1995-07       Impact factor: 6.318

Review 5.  Decoding pathogenesis of slow-channel congenital myasthenic syndromes using recombinant expression and mice models.

Authors:  José David Otero-Cruz; Carlos Alberto Báez-Pagán; Luisamari Dorna-Pérez; Gary Emanuel Grajales-Reyes; Rosaura Teresa Ramírez-Ordoñez; Carlos A Luciano; Christopher Manuel Gómez; José Antonio Lasalde-Dominicci
Journal:  P R Health Sci J       Date:  2010-03       Impact factor: 0.705

6.  PAX3 mutations and clinical characteristics in Chinese patients with Waardenburg syndrome type 1.

Authors:  Juan Wang; Shiqiang Li; Xueshan Xiao; Panfeng Wang; Xiangming Guo; Qingjiong Zhang
Journal:  Mol Vis       Date:  2010-06-22       Impact factor: 2.367

7.  EPHA4 haploinsufficiency is responsible for the short stature of a patient with 2q35-q36.2 deletion and Waardenburg syndrome.

Authors:  Chuan Li; Rongyu Chen; Xin Fan; Jingsi Luo; Jiale Qian; Jin Wang; Bobo Xie; Yiping Shen; Shaoke Chen
Journal:  BMC Med Genet       Date:  2015-04-11       Impact factor: 2.103

8.  A novel missense mutation of the paired box 3 gene in a Turkish family with Waardenburg syndrome type 1.

Authors:  Filiz Hazan; A Taylan Ozturk; Hamit Adibelli; Nurettin Unal; Ajlan Tukun
Journal:  Mol Vis       Date:  2013-01-29       Impact factor: 2.367

9.  Clinical manifestations of Waardenburg syndrome in a male adolescent in Mali, West Africa.

Authors:  Pascal James Imperato; Gavin H Imperato
Journal:  J Community Health       Date:  2015-02

10.  PAX3 gene deletion detected by microarray analysis in a girl with hearing loss.

Authors:  Malgorzata Drozniewska; Olga Haus
Journal:  Mol Cytogenet       Date:  2014-04-29       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.